Until ten years ago neurological complications of chronic renal failure were no more than incidents marking the downward course of the primary ,condition and were of little clinical interest. Since the advent of effective treatment by himodialysis and by renal homotransplantation the neurological aspects of renal failure and the complications associated with its treatment have become increasingly important.
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During the past four years, Dr I R Williams, Dr A M Davison, Dr C H Hawkes, Dr J S Robson ,and I have studied some neurological features of -renal failure and, in particular, have investigated the peripheral nerve affection therein. A group of *67 patients has been followed for 1-5 (mean 2.8) years; 34 of these were treated by dietary restrictions alone, 30 were maintained on intermittent hmmodialysis, and 13 were studied before and -after renal transplantation.
In the early days of haemodialysis neuropsychiatric complications were often recorded. 'These were particularly liable to occur after prolonged periods of dialysis. Restlessness, depression and headache during the period of dialysis are still fairly common. Fits occasionally occur. Of our group of 30 dialysed patients 5 suffered 'from grand mal epileptic convulsions, and in 2 of Athese the fits occurred during a dialysis session. The precise changes which give rise to fits in renal failure and after dialysis are still unknown. It seems clear, however, that fits are associated with Tapid changes in blood biochemistry and acidbase balance, and that they are much less frequent Jf hmmodialysis is instituted on a less aggressive basis so that changes in the blood pH and urea concentration are made more gradually.
Many studies during the past decade have shown that peripheral neuropathy is common in chronic renal failure. The incidence of neuropathy in various series has varied between 13 % and 86%. The different diagnostic criteria employed explain the widely differing prevalence rates. In our own group of patients treated by heemodialysis one third showed evidence of peripheral neuropathy as manifested by impairment of sensation, or by diminished reflexes. In most instances the polyneuropathy seen in patients suffering from chronic renal failure is distal and symmetrical in distribution and affects sensory and motor functions equally. Occasional patients, however, complain of intense painful paresthesie in the feet resembling the 'burning feet' syndrome caused by vitamin deficiency. Impaired nerve conduction, in the absence of clinically overt peripheral nerve affection, occurs in patients with chronic renal failure. Serial studies of our patients who were treated by dietary restriction alone show that the decrease in motor nerve conduction velocities parallels the degree of renal failure as reflected in the plasma concentrations of urea and creatinine. We have found no other consistent correlation, and inparticular there was no significant relationship between nerve conduction velocities and the plasma concentrations of calcium or magnesium, such as was described by Stewart et al. (1968) . Our findings in this regard are similar to those of Hollinrake etal. (1970) .
Thirty patients were each dialysed twice weekly for a total of 28 hours in the week. All were given vitamin supplements. This group of patients showed a progressive reduction in motor nerve conduction velocities during the first year after institution of hiemodialysis. Deterioration in motor peripheral nerve function involved all the computedfrom all resultsfor the anterior tibial nerve in 30patients treated by haemodialysis. Ankle latency refers to the latency in milliseconds between stimulation ofthe anterior tibial nerve at the ankle, and the muscle response in extensor digitorum brevis. Leg velocity gives results in metres per second ofthe conduction velocity in motorfibres ofthe anterior tibial nerve between knee and ankle nerves studied (median, ulnar and anterior tibial) and was also reflected by a gradual increase, during the first year, of the average latency of the H reflex. A slowly progressive improvement in peripheral nerve conduction velocities was manifest one year after the start of treatment and was sustained during the ensuing two years. This pattern of change, statistically validated, is illustrated for the anterior tibial nerve in Fig 1, which shows the regression curve computed from all the results of patients in the group.
During the course of this study 11 patients who were being treated by chronic haemodialysis developed serum hepatitis, and later made a good recovery. Most of these patients had been treated for more than a year before they developed hepatitis, and their conduction velocities were showing a predictable improvement. During the course of the liver disease there was a significant fall in conduction velocities but these again showed a tendency to improve after recovery from the infection. These results have been reported in detail elsewhere (Davison et al. 1972) .
In those patients who successfully underwent renal transplantation, improvement in nerve conduction velocities was discernible within three months of the operation and was thereafter sustained, so that after one year average nerve conduction velocities were within the normal range.
Discussion
The nature of the pathological changes in the peripheral nerves of uremic patients has been studied by Asbury et al. (1963) and was recently comprehensively reviewed by Thomas et al. (1971) . There is distal axonal degeneration together with paranodal demyelination. The factors which cause peripheral neuropathy in chronic renal failure are still unknown; it is unlikely that dietary or vitamin deficiency are responsible, nor is there evidence that ischemic damage to the nerves is causal. Lipid peroxides accumulate in the serum of patients with renal failure and may be neurotoxic but direct evidence for this causation is lacking.
Of particular interest is the deterioration which occurs initially after the institution of chronic haemodialysis. Hemodialysis is capable of restoring blood urea to normal values fairly rapidly. Intermittent peritoneal dialysis results in improvement in the neuropathy in patients with chronic renal failure despite continuing high blood concentrations of urea and creatinine. It is unlikely, therefore, that urea or creatinine is responsible for the impairment of nerve conduction velocities. An inhibitor of transketolase activity has been found in the serum of patients with chronic renal failure. Transketolase seems necessary to preserve the integrity of the myelin sheath. Intermittent hemodialysis removes this inhibitory factor only after thirty weeks or more. A recent intriguing observation suggests that dialysis of very high efficiency may cause increased aggravation of peripheral neuropathy (Christopher et al. 1971) . It is possible that the deterioration in peripheral neuropathy which occurs in the year after the institution of chronic intermittent hemodialysis is due to neurotoxic factors, whose molecular weights are greater than that of urea, and which are relatively slowly removed by treatment. The deterioration, therefore, would represent no more than continuation of metabolic damage to peripheral nerves associated with urTmia, and the subsequent improvement in the second and third years of intermittent hemodialysis might result from final removal of these postulated toxic metabolites. It is at least as likely that dialysis itself may cause an increase in damage to axon or myelin sheath by removing from the blood some factors which are essential to the maintenance of normal peripheral nerve function. Support for this thesis is given by the marked improvement in peripheral nerve conduction velocities which follows renal homotransplantation.
Recent work suggests that mechanistic or biochemical evaluation of dialysis based on the rate of clearance of urwmic products does not fully reflect the biological effectiveness of treatment. The study of neurological parameters such as peripheral nerve conduction velocities or the EEG in dialysed patients provides functional criteria of the therapeutic worth of different types Section ofNeurology 873 of dialyser and different regimes of dialysis. It may be that in the future the determination of the molecular weight and perhaps later the nature of the neurotoxic factors affecting patients with chronic renal failure will throw light on the pathogenesis of other forms of peripheral neuropathy.
Dr J L H O'Riordan (Middlesex Hospital, London WI)
Calcium and the Nervous System
Considerable advances have been made in the field of mineral metabolism in recent years and their clinical impact is beginning to be felt. Here I will briefly review some of the advances and, where possible, their relevance to neurologists. The structures of parathyroid hormone of bovine and porcine origin are now known; they differ in their amino acid sequence at 7 of the 84 positions. Highly sensitive radioimmunoassays have been developed for parathyroid hormone using antibodies against bovine parathyroid hormone, produced by immunizing guinea-pigs. Human parathyroid hormone has only been isolated in microgram amounts and it has been shown immunologically to differ from parathyroid hormone in the other two species. There is, however, sufficient cross-reactivity for human parathyroid hormone to be measured using the immunoassay systems. Very high concentrations of human parathyroid hormone are found in hyperparathyroid patients with clear-cut radiological changes of osteitis fibrosa. Lower concentrations are found in hyperparathyroid patients without bone disease and it is reasonable now to abandon the postulate that the development of bone disease is due to the secretion of a different type of hormone. Rather it seems that this is due to the higher secretion rate of hormone from the larger tumours which are found in patients with osteitis fibrosa. Another concept that can be abandoned is that there are two forms of parathyroid hormone (the one raising serum calcium and the other producing phosphaturia), since a peptide with the sequence of the first 34 amino acids of the amino terminal part of bovine parathyroid hormone has been synthesized and found to have both phosphaturic and calcium mobilizing activity (O'Riordan et al 1971) .
The concentration of parathyroid hormone in patients without radiQlogical bone disease is linearly related to serum calcium; assay of parathyroid hormone can, therefore, be useful in establishing the cause of severe hypercalcemia, which may present to a neurologist as the cause of a confusional state and simulate a cerebral tumour. If the hypercalcoemia were due to any other cause, then the patient's parathyroid glands would be suppressed and no hormone would be detectable in the circulation.
Last year Earl Sutherland was awarded a Nobel prize for his work on the enzyme adenyl cyclase, which converts adenosine triphosphate (ATP) to 3'5' cyclic adenosine monophosphate (cAMP). He developed the concept that cAMP is a second intracellular 'messenger', activating the specific properties of the cell. Many of the peptide hormones specifically activate this system in their target tissues. The system can be represented as: ATP -cAMP (second messenger)adenyl cyclase hormone (first messenger) Chase et al. (1969) showed that parathyroid hormone activates the adenyl cyclase system of the cell membrane of tubules prepared from renal cortex. It has no effect on the adenyl cyclase system of the renal medulla which is, however, activated by antidiuretic hormone instead. When parathyroid hormone is given and adenyl cyclase is activated in the kidney there is increased urinary excretion of cAMP.
Pseudohypoparathyroidism may present to the neurologist as hypocalc2emia, leading, for example, to epilepsy. It may be difficult to differentiate from other causes of hypocalcwemia if the facies is nrot typical and if there is not marked shortening of some of the metacarpals. The syndrome of pseudohypoparathyroidism is characterized by end-organ resistancethere is failure to respond to endogenous or exogenous parathyroid hormone. In the Ellsworth-Howard test this is reflected by a failure of parathyroid hormone to produce phosphaturia. This is not a reliable test, but it can now be made far more specific since pure parathyroid hormone can be infused and the specific effect of parathyroid hormone on adenyl cyclase monitored by measuring the excretion of 3'5' cAMP in the urine. Nor-
